Top Stories
-
Jan Hilgeman is one of the rare long-term survivors of pancreatic cancer, and Columbia researchers are now studying her cells in hopes of developing a potential treatment for others with the disease.
-
An implantable pump that has the potential to transform brain cancer treatment was found safe and effective in people in a study at Columbia University.
Topic
-
Columbia's Barbara Pro, MD, widely recognized for her expertise in developing novel drug treatments for lymphoma, shares her insights.
-
High school students from the Herbert Irving Comprehensive Cancer Center's summer science program presented their research findings to Columbia scientists at an Oct. 17 poster session.
Topic
Latest News
- March 30, 2022
The study's findings underscore the importance of identifying different treatments for different subpopulations of glioma patients.
Topic
- March 24, 2022
Columbia's Lisa A. Kachnic, MD, a pioneer in radiation oncology, discusses the advancements made in the field of radiotherapy and the innovation to come.
- March 22, 2022
With colon cancer becoming more common in people under 50, screening guidelines have changed.
Topic
- March 17, 2022
In the future, bacteria may be let loose in the body to seek and destroy cancer cells, but the bacteria need a way to hide from our immune system. Columbia biomedical engineers may have a solution.
- March 17, 2022
In the early days of Columbia's cancer program, several incredible women physicians and scientists made key discoveries in the field.
- March 7, 2022
Having a rapport with kids is a critical part of the job for James Church and other Columbia colorectal surgeons who treat people with hereditary colon cancer.
Topic
- March 3, 2022
Lung cancer often spreads to the brain. Columbia scientists have now uncovered a tactic used by metastases to hide in the brain and identified a drug combination that can potentially target them.
Topic
- February 22, 2022
By applying artificial intelligence to standard-of-care imaging, Columbia cancer researchers can predict how well immunotherapy will work for patients with melanoma.
Topic
- February 4, 2022
A clinical trial led by a Columbia neuro-oncology team suggests that a new type of anti-cancer drug has promise for patients with glioblastoma.
- January 27, 2022
Active surveillance has emerged as a safe option for some thyroid cancers, illustrating that less can be more in thyroid cancer management.
